The article discusses a new study from researchers at the University of Connecticut that explores the potential of targeting and eliminating senescent cells, also known as "zombie cells," to extend lifespan and healthspan in mice.
The researchers used genetic engineering to introduce a "suicide gene" into the mice's genome that could be activated to selectively kill p21-positive senescent cells. By administering a drug to activate this suicide gene once a month in older mice, the researchers were able to significantly extend the mice's lifespan by an average of 3 months, with the oldest treated mouse living to 43 months (roughly 130 human years).
The treated mice not only lived longer, but were also healthier, exhibiting improved physical function like faster walking speed and stronger grip strength compared to untreated mice of the same age. The researchers believe this approach of eliminating senescent cells could have therapeutic potential for age-related diseases like diabetes and Alzheimer's.
However, the article also notes potential downsides, as senescent cells play a protective role in preventing uncontrolled cell proliferation and cancer. The researchers are now testing drugs and immunotherapy approaches to target senescent cells, with the goal of human trials in the next 2-5 years.
The article also discusses other interventions that have been shown to extend lifespan, such as caloric restriction and maintaining strong social connections, highlighting that a combination of approaches may be needed to maximize healthy longevity.
إلى لغة أخرى
من محتوى المصدر
www.medscape.com
الرؤى الأساسية المستخلصة من
by Christina Sz... في www.medscape.com 08-14-2024
https://www.medscape.com/viewarticle/how-targeting-zombie-cells-could-help-extend-health-span-2024a1000exvاستفسارات أعمق